## Answer
(model generated chain of thought explanation)

Given the patient's symptoms, including feelings of guilt, loss of appetite (unintentionally lost 15 pounds), sleep disturbances, decreased performance at work, and numbness in his feet and fingers without erectile dysfunction, it is likely that he is experiencing depression. The presence of numbness and inability to maintain an erection could be indicative of neuropathy, which is a common complication of untreated depression.

The patient's past medical history of diabetes and the fact that he is on metformin for this condition are also relevant. Metformin can have side effects such as gastrointestinal issues and increased risk of lactic acidosis in patients with renal insufficiency or other underlying conditions, but it does not directly treat depression.

Considering the treatment options for depression, which include medications like selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs), we need to identify which process is inhibited by these medications.

A. Norepinephrine and serotonin reuptake - This option refers to the mechanism of action for SSRIs, a class of antidepressants commonly used in treating depression.
B. Amine degradation - This is related to the metabolism of certain neurotransmitters like dopamine and norepinephrine but not directly relevant to the primary treatment of depression.
C. Norepinephrine and dopamine reuptake - This option refers to the mechanism of action for TCAs, another class of antidepressants that can be used in treating depression.
D. Dopamine receptor activation - While some antidepressants may have effects on dopamine receptors, this is not a primary mechanism of action for the most commonly prescribed medications for depression.

Therefore, considering the patient's presentation and the typical treatment options for depression, the best medication for this patient would inhibit norepinephrine and serotonin reuptake, which aligns with the mechanism of action for SSRIs.